EPZM
Epizyme, Inc
EPZM
EPZM
Delisted
EPZM was delisted on the 11th of August, 2022.
151 hedge funds and large institutions have $1.1B invested in Epizyme, Inc in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 45 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
27% less capital invested
Capital invested by funds: $1.5B → $1.1B (-$405M)
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
Holders
151
Holding in Top 10
7
Calls
$30.4M
Puts
$2.1M
Top Buyers
| 1 | +$10.6M | |
| 2 | +$9.1M | |
| 3 | +$7.4M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$6.24M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$5.6M |
Top Sellers
| 1 | -$32M | |
| 2 | -$22.3M | |
| 3 | -$10.4M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$10M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$9.68M |